- 专利标题： S-nitrosoglutathione (GSNO) and GSNO reductase inhibitors for use in therapy
-
申请号： US16336984申请日： 2018-05-08
-
公开(公告)号： US10925858B2公开(公告)日： 2021-02-23
- 发明人: Inderjit Singh , Avtar K. Singh
- 申请人： MUSC FOUNDATION FOR RESEARCH DEVELOPMENT , THE US GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
- 申请人地址： US SC Charleston; US DC Washington
- 专利权人： MUSC FOUNDATION FOR RESEARCH DEVELOPMENT,THE US GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
- 当前专利权人： MUSC FOUNDATION FOR RESEARCH DEVELOPMENT,THE US GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
- 当前专利权人地址： US SC Charleston; US DC Washington
- 代理机构： Parker Highlander PLLC
- 国际申请： PCT/US2018/031622 WO 20180508
- 国际公布： WO2018/208793 WO 20181115
- 主分类号： A61K31/4178
- IPC分类号： A61K31/4178 ; A61K38/06 ; A61K45/06
摘要：
The present disclosure provides methods for the treatment of neurological deficits by the administration of GSNO or GSNO reductase inhibitor. Further provided herein are methods of treating autoimmune diseases by administering GSNO or GSNO reductase inhibitor.
公开/授权文献
信息查询
IPC分类:
